Upcoming Medicare Billing Changes for Federally Qualified Health Centers

Starting July 1, 2025, Federally Qualified Health Centers (FQHCs) will encounter significant adjustments in the billing process for Medicare Part B preventive vaccines. Initiated by the Centers for Medicare & Medicaid Services (CMS), these changes are designed to offer FQHCs more flexibility in billing while imposing new cost report obligations. This update underscores the growing importance of navigating regulatory compliance requirements and managing cash flow efficiently.

From this date forward, FQHCs must bill for four specific vaccines—pneumococcal, influenza, hepatitis B, and COVID-19—along with their administration to original Medicare beneficiaries at the point of service. Notably, these changes will not affect billing for Medicare Advantage participants. Regardless of whether a qualifying visit occurs, providers can bill for vaccines and their administration following established Medicare Part B guidelines.

Providers are required to use the CMS-1450 (UB-04) claim form for billing, with immediate payment offered while mandating reconciliation with actual costs in the annual Medicare cost report. Vaccine payments and billing counts are documented in the Provider Statistical & Reimbursement (PS&R) Report, Type 772, which is vital for completing Worksheet B-1 of the cost report. FQHCs must ensure accurate billing at the time of service and meticulous cost tracking to reconcile Medicare payments effectively.

These modifications aim to enhance cash flow by enabling immediate compensation and necessitate close coordination between billing and finance departments. FQHCs should review and refine their charge capture and vaccine cost tracking processes to ensure precise billing and thorough reconciliation in Medicare cost reporting. For in-depth guidance on Medicare billing for FQHCs, it is advisable to consult with professionals from the Community Health Centers (CHCs) team.